查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138408

全球藥物遞送納米技術市場-2022-2029

Global Nanotechnology in Drug Delivery Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

由於慢性病患病率的增加、各種具有成本效益的新產品的推出和新技術的進步，對納米技術在藥物遞送中的需求不斷增加，全球納米技術在藥物遞送中的市場正在增長。由於多種因素，該市場正在增長。

納米技術藥物輸送的批准和各種新技術的進步預計將推動市場的增長。

由於全球不健康的生活方式和環境變化，癌症、腫瘤、心髒病和冠狀動脈疾病等慢性疾病的患病率不斷上升，推動了市場的發展。根據世界衛生組織（WHO）的數據，癌症將成為 2020 年的首要死因，導致全球 960 萬人死亡，每年診斷出超過 300,000 例病例。納米醫學通過減少副作用在改善人類健康方面發揮著重要作用。目前，基於納米技術的藥物遞送他汀類藥物和納米抗生素可作為預防癌症和冠狀動脈疾病等某些疾病的有效治療方法。納米抗生素計劃利用這種效應，通過應用提供抗菌治療的納米顆粒和改善抗生素藥物輸送的納米級生物分子來增強對感染的治療。

FDA 的批准正在增加。具有廣泛研究和開發各種疾病的創新藥物的擴散為這個市場創造了充足的機會。例如，2020 年 6 月 17 日，Nanobiotix 公司收到了美國 FDA 關於開發有效設計的基於鉑的化療的反饋。公司通過支持未來新藥申請 (NDA) 所需的研究設計，推進基於化學、製造和控制 (CMC) 開發的治療頸部和頭部癌症的 III 期臨床試驗，因為它已經開始。

與藥物輸送中的納米技術相關的擔憂預計將阻礙市場增長。

隨著納米技術程序可能導致嚴重的環境危機並且不環保，環境問題日益增加。使用化學品提取納米顆粒會增加對環境的污染。與健康相關的擔憂也在抑制市場增長。

行業分析

全球藥物輸送納米技術市場根據波特五力、監管分析、供應鏈分析和定價分析等各種行業因素對市場進行了深入分析。

納米技術在藥物輸送全球市場報告中提供了對大約 45 多個市場數據表、40 多個數字和 180 頁的訪問。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 納米技術藥物遞送系統的批准增加
      • 技術進步的增加
    • 限制因素
      • 環境和健康風險增加
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析

第 6 章按技術分類

  • 用於納米技術行業的藥物輸送膠束
  • 納米粒子
  • 脂質體
  • 納米晶體
  • 其他

第 7 章按應用程序

  • 抗感染
  • 神經區域
  • 抗炎/免疫學
  • 腫瘤學
  • 循環系統/生理學
  • 其他

第 8 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 9 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 技術基準
  • 值得關注的重點公司列表

第 10 章公司簡介

  • AbbVie Inc.
    • 公司概況
    • 技術組合和內容
    • 主要亮點
    • 財務摘要
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • Nanobiotix
  • NanoCarrier Co. Ltd.
  • NanOlogy LLC
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Ceramisphere Health Pvt Limited
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Lena Nanoceutics Ltd.

第11章 全球藥物遞送納米技術市場-DataM

簡介目錄
Product Code: DMMD2546

Market Overview

Nanotechnology in Drug Delivery Market size was valued US$ 51.4 billion in 2021 and is estimated to reach US$ 203.6 billion by 2029, growing at a CAGR of 17.9% during the forecast period (2022-2029).

Nanotechnology in drug delivery is the rapidly developing way of providing effective treatment for various diseases. Nanotechnology-based drugs can potentially deliver the drugs to targeted and affected parts of the human body by reducing the side effects. Nanotechnology drug delivery utilizes the nanoscale range nanoparticles like liposomes, chemotherapeutic agents, biological agents, etc., to deliver the therapeutic agents to specifically targeted sites in a controlled manner. The nanotechnology drug delivery has certain benefits, including improving the ability to deliver poorly water-soluble drugs, reduce drug accumulation within healthy tissue, combine therapeutic and diagnostic modalities through one agent, transportation of drugs across epithelial and endothelial barriers, protection from the biological environment, effective treatment can be achieved by retaining the drug in the body long time.

Market Dynamics

The global nanotechnology in drug delivery market is growing due to several factors such as rising demand for nanotechnology in drug delivery due to the increasing prevalence of chronic diseases, various new cost-effective product launches and novel technological advances.

Rising approvals of nanotechnology drug delivery and various new technological advancements are expected to drive market growth.

The market is driven by the rising prevalence of chronic ailments like cancer, tumor, heart disease, coronary artery disease due to unhealthy life styles and changing environments worldwide. According to the World Health Organization, in 2020, Cancer is the leading cause of death, accounting for 9.6 million people who died worldwide, and more than 300000 patients are being diagnosed each year. Nanomedicine plays a vital role in enhancing human health by reducing side effects. Currently, nanotechnology-based drug delivery statins, nano antibiotics, and other agents can be utilized as a valid treatment for preventing certain diseases like cancer, coronary artery disease, and many others. Nanoantibiotics will utilize this effect to enhance infection treatment via the application of both nanoparticles with antimicrobial therapies and nanosized biological molecules for improved antibiotic drug delivery.

There is a rise in FDA approvals. A surge in innovative drugs through extensive research and developments in various diseases has created ample opportunity for this market. For instance, on 17th June 2020, Nanobiotix Company received feedback on developing effective designed platinum-based chemotherapy from the US FDA. The Company had started to advance Phase III clinical trials to treat neck and head cancer based on chemistry, manufacturing, and controls (CMC) development through necessary study design to support the future New Drug Application (NDA).

Concerns associated with nanotechnology in drug delivery is expected to hamper the market growth.

Increasing environmental concerns as nanotechnology procedure are not environment friendly that can lead to critical environmental hazards. Usage of chemicals for extraction of nanoparticles will add up in polluting environment. Health related concern is also a factor that can restraint the growth of market.

Industry Analysis

The global nanotechnology in drug delivery market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis.

Segment Analysis

Applications segment is expected to hold the largest market share in global nanotechnology in drug delivery market

The global nanotechnology in the drug delivery market is segmented based on technology, applications, and region.

In terms of technology type, the global nanotechnology in the drug delivery market is bifurcated into micelles, nanoparticles, liposomes, nanocrystals, etc. The nanoparticles segment has the highest market share due to the increasing launching of advanced technology-based nanoparticles for effective treatment and avoiding the side effects due to harmful drugs. For instance, on 5th Nov 2019, MIT engineers developed the nanoparticle coated with "right-handed" molecules to enhance drug delivery.

Depending on technology type, micelles, nanoparticles, liposomes, nanocrystals segments are also growing faster due to increasing the demand for effective treatment drugs with the rising new nano-based medicine. For instance, on 14th May 2020, NanOlogy Company had been launched a new drug delivery injection Nanopac for targeting the treatment of Pancreatic Cancer and Mucinous Cystic Neoplasms.

Depending on the applications, global nanotechnology in the drug delivery market is divided into anti-infective, neurology, anti-inflammatory/immunology, oncology, cardiovascular/physiology, and others. Among these, the anti-inflammatory/immunology segment had the highest share in 2019. This is primarily due to rising investment in developing new drugs for the immune system for various diseases. For instance, Ventus launched with $60 million from Versant Ventures and GV. Working out of dual headquarters in Waltham and Montreal, the biotech plans to create drugs that target the immune system's first defense line, known as the innate immune system. For instance, on 6th May 2020, Ventus Therapeutics Company received USD 60 Million in funding to develop medicines that have been targeted the innate immune system.

Similarly, anti-infective, neurology, oncology, cardiovascular/physiology segments are also growing faster due to the increase in the prevalence of chronic ailments like cancer, cardiovascular, neurological diseases, etc., the globe. According to the World Health Organization, an estimated 31% of all global deaths, around 17.9 million people, die each year due to cardiovascular diseases. This propels the advanced treatment methods for treating the diseases through the nanotechnology drug delivery systems.

Geographical Analysis

North America region holds the largest market share in the global nanotechnology in drug delivery market

By region, the global Nanotechnology in the Drug Delivery market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America is the dominant region for global nanotechnology in the drug delivery market. It is expected to grow at the highest CAGR during the forecasted period due to leading healthcare players with advanced technology followed by the European region. Furthermore, the rising prevalence of chronic diseases like cancer, cardiovascular, etc., in this region due to unhealthy lifestyles and diet has propelled nanotechnology's demand in the drug delivery market. According to a recent study by American Cancer Society researchers, in the United, 750000 cases were diagnosed, at least 42% of cancers cases in 2020. This propels the demand for the electronics avionics market during the forecast period.

The Asia Pacific is also growing faster for nanotechnology in the drug delivery market, owing to the prevalence of chronic diseases like cancer, cardiovascular, etc. According to the Cancer Organization in 2020, the Asia Pacific region has accounted for around 5.9 million cases were diagnosed and is projected to reach around 7.8 million new cancer cases by 2050. This will propel the demand for advanced treatment for drug delivery through nanotechnology.

Competitive Landscape

The global nanotechnology in the drug delivery market is highly competitive with several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Ceramisphere Health Pvt Limited, Cristal Therapeutics, CYTIMMUNE SCIENCES, Inc., Nanobiotix, NanoCarrier Co. Ltd., NanOlogy LLC, EnColl Corporation, EyePoint Pharmaceuticals, AbbVie Inc., Aquanova AG, BlueWillow Biologics, Camurus AB, Celgene, Inc., Lena Nanoceutics Ltd. are the leading market players with significant market share.

There is rising FDA approval for adopting advanced technology like nanotechnology to treat various chronic diseases like cancer, cardiovascular diseases, etc. has created a huge opportunity for this market. For instance, on 9th June 2020, NanOlogy Company had started clinical trials using nanotechnology-based drug delivery devices like intratumoral (IT) injections of NanoPac to treat lung cancer with FDA permission. Companies are entering into collaborations, acquisitions, mergers, and licensing for increasing their market penetration.

Key players focus on various strategic initiatives such as merger & acquisition, geographical expansion, new product launches, and increasing R&D expenditure to stay competitive. For instance, in May 2021, Nanobiotix and Lianbio announced their partnership to develop first in class radio-enhancer NBTXR3 over therapeutic combination in Asian markets.

Key Companies to Watch

AbbVie Inc:

Overview: AbbVie is America-based biopharmaceutical company that is publicly traded. It was founded in 2013 and is headquartered in Illinois, United States. Due to the spin-off of Abbott Laboratories it was originated. It is research based pharmaceutical manufacturer.

Product Portfolio:

Leupron Depot: It is injectable gonadotropin releasing hormone medication used for management of endometriosis and pain relief.

Key Developments: In March 2022, Abbvie announced its acquisition of Syndesi Therapeutics for $1 billion.

The global nanotechnology in drug delivery market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Rising approvals of nanotechnology drug delivery system
      • 4.1.1.2. Increasing technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Increasing environmental and health risk
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
    • 6.1.2. Market Attractiveness Index, By Technology Segment
  • 6.2. Micelles for Nanotechnology in Drug Delivery the industry
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Nanoparticles
  • 6.4. Liposomes
  • 6.5. Nanocrystals
  • 6.6. Others

7. By Applications

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications Segment
    • 7.1.2. Market Attractiveness Index, By Applications Segment
  • 7.2. Anti-infective
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Neurology
  • 7.4. Anti-inflammatory/Immunology
  • 7.5. Oncology
  • 7.6. Cardiovascular/Physiology
  • 7.7. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications

9. Competitive Landscape

  • 9.1. Key Developments and Strategies
  • 9.2. Company Share Analysis
  • 9.3. Technologys Benchmarking
  • 9.4. List of Key Companies to Watch

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Technology Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Cristal Therapeutics
  • 10.3. CYTIMMUNE SCIENCES, Inc.
  • 10.4. Nanobiotix
  • 10.5. NanoCarrier Co. Ltd.
  • 10.6. NanOlogy LLC
  • 10.7. EnColl Corporation
  • 10.8. EyePoint Pharmaceuticals
  • 10.9. Ceramisphere Health Pvt Limited
  • 10.10. Aquanova AG
  • 10.11. BlueWillow Biologics
  • 10.12. Camurus AB
  • 10.13. Celgene, Inc.
  • 10.14. Lena Nanoceutics Ltd.

LIST NOT EXHAUSTIVE

11. Global Nanotechnology in Drug Delivery Market - DataM

  • 11.1. Appendix
  • 11.2. About Us and Applications
  • 11.3. Contact Us